Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 6,920 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Sleep, Knee Osteoarthritis
Interventions: Magnesium Threonate, Control; Drug · Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Irritable Bowel Syndrome
Interventions: Diet A - elimination diet, Diet B - healthy eating diet; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Multiple Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Demyelinating Diseases, Autoimmune Diseases, Immune System Diseases
Interventions: Music Training Intervention, Music Listening; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Lung Cancer
Interventions: RAD001; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Obesity, Water; Lack of, Breast Feeding, Tooth Erosion, Dental Plaque, Infant Obesity, Feeding Behavior, Mother-Child Relations, Dietary Habits, Dental Caries
Interventions: Family Spirit Nurture (FSN), Control Program, Water Delivery; Behavioral · Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 13 Years and older · Female only
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Shiprock, New Mexico

Conditions: Autism Spectrum Disorder
Interventions: MINDful TIME; Behavioral
Lead sponsor: Southwest Autism Research & Resource Center; Other
Eligibility: 13 Years to 18 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Infant,Premature
Interventions: Assessment of oxygenation instability, Determination of mechanisms of hypoxemia episodes, Assessment of respiratory instability, apneic threshold of CO2, Assessment of peripheral chemoreceptor function, Assessment of central chemo-receptor function; Other
Lead sponsor: University of Miami; Other
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Developmental Delay (Disorder)
Interventions: Parent Education - Promoting Playfulness; Behavioral
Lead sponsor: Florida Gulf Coast University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Peyronie's Disease
Interventions: CCH administration, Control - Crossover to CCH, RestoreX; Drug · Device
Lead sponsor: Charitable Union for the Research and Education of Peyronie's Disease; Other
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Orem, Utah

Conditions: Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis, Myasthenia Gravis, Lambert-eaton Myasthenic Syndrome, Primary Lateral Sclerosis, Spinal Muscular Atrophy, Charcot Marie Tooth Disease (CMT), Fascioscapulohumeral Muscular Dystrophy, Inclusion Body Myositis, Mitochondrial Myopathy, Nemaline Myopathy, Centronuclear Myopathy, Postpolio Syndrome, Pompe Disease (Late-onset), Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Spastic Paraplegia, Postural Orthostatic Tachycardia Syndrome (POTS), Progressive Muscular Atrophy
Interventions: Whole-body Electrical Muscle Stimulation Exercise; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Resistance Training
Interventions: Bodyweight exercises (push-ups, angled-rows, bodyweight squats) on weekdays; Behavioral
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 19 Years and older
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Auburn, Alabama

Conditions: Spinal Cord Injuries, Cognitive Dysfunction, Cognitive Impairment, Acute Spinal Cord Injury
Interventions: game-like computerized activities; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: HIV Associated Polyneuropathy
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (AVNS); Device
Lead sponsor: University of Miami; Other
Eligibility: 50 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pain, Postoperative
Interventions: Ibuprofen 600 mg, Local anesthetic Group 1, Placebo oral capsule, Local anesthetic Control; Drug
Lead sponsor: Satheesh Elangovan; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Single Ventricle Defect
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Months to 10 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Alcohol Use Disorder
Interventions: Suvorexant 10 mg, Placebo; Drug · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteoarthritis
Interventions: PainCOACH; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Durham, North Carolina • Smithfield, North Carolina

Conditions: Sleep Disturbance, Inflammation, Quality of Life, Bereavement, Spouses
Interventions: Targeted Cognitive Behavior Therapy for Insomnia, Information-Only Control; Behavioral · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive, Respiration Disorders
Interventions: Placebo, Lemborexant 10 mg; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 45 Years to 90 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 11
States / cities: Glendale, Arizona • San Diego, California • Brandon, Florida + 7 more

Conditions: Nutrition, Healthy
Interventions: Nourish intervention then no intervention, no intervention then Nourish intervention; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Gastric Transit Time
Interventions: metoclopramide; Drug
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Adverse Effect of Other Agents Primarily Affecting the Cardiovascular System, Initial Encounter
Interventions: Cigarette, NIDA test type with 16.6 mg nicotine, Cigarette, NIDA test type with <0.45 mg nicotine, Electronic cigarette with 18 mg/ml nicotine, Electronic Cigarette with no nicotine, Moist snuff, Sham Smoking, Secondhand cigarette smoke (SHS), Conditioned, filtered air, Sham Moist Snuff; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 50 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Opioid Use Disorder
Interventions: active tDCS, sham tDCS; Device
Lead sponsor: Butler Hospital; Other
Eligibility: 21 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Stress, Anxiety, Depression
Interventions: Compassionate Care, Relaxing with Nature; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 365 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty

Defining Objective Markers of Compliance for Dietary Therapies in IBS

Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study

Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Preventing Early Childhood Obesity, Part 1: Family Spirit Nurture, 3-9 Months

Mindfulness-Based Intervention for Teens With Autism Spectrum Disorder and Their Caregivers

Oxygenation Instability and Maturation of Control of Breathing in Premature Infants

Promoting Playfulness

Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Minute Calisthenics: A Daily, Habit-Based, Bodyweight Resistance-Training Program

Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study

Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy

Pre-Emptive Analgesia in Dental Implant Surgery

Cerebral Blood Flow in Single Ventricles Throughout Staged Surgical Reconstruction

Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

Internet-Based Osteoarthritis Pain Coping Skills Intervention

Rest to Overcome Loss and Reduce Risk

A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease

Nourish Clinical Trial

Study to Evaluate the Efficacy of Oral Dissolving Metoclopramide Before Video Capsule Endoscopy

Cardiovascular Assessment of the Effects of Tobacco and Nicotine Delivery Products

tDCS to Decrease Opioid Relapse (UH3)

Single-Session Web-Based Training in Self-Compassion